Chemed Operating Margin 2010-2024 | CHE

Current and historical operating margin for Chemed (CHE) over the last 10 years. The current operating profit margin for Chemed as of March 31, 2024 is 14.18%.
Chemed Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-03-31 $2.29B $0.34B 14.82%
2023-12-31 $2.27B $0.34B 15.06%
2023-09-30 $2.23B $0.31B 13.97%
2023-06-30 $2.19B $0.31B 13.95%
2023-03-31 $2.16B $0.33B 15.11%
2022-12-31 $2.14B $0.34B 16.07%
2022-09-30 $2.13B $0.36B 16.91%
2022-06-30 $2.14B $0.37B 17.37%
2022-03-31 $2.14B $0.35B 16.43%
2021-12-31 $2.14B $0.34B 16.04%
2021-09-30 $2.13B $0.39B 18.21%
2021-06-30 $2.12B $0.37B 17.41%
2021-03-31 $2.09B $0.39B 18.66%
2020-12-31 $2.08B $0.39B 18.71%
2020-09-30 $2.07B $0.32B 15.62%
2020-06-30 $2.02B $0.31B 15.54%
2020-03-31 $1.99B $0.29B 14.40%
2019-12-31 $1.94B $0.26B 13.25%
2019-09-30 $1.88B $0.25B 13.17%
2019-06-30 $1.84B $0.24B 13.28%
2019-03-31 $1.81B $0.24B 13.07%
2018-12-31 $1.78B $0.24B 13.63%
2018-09-30 $1.75B $0.23B 13.29%
2018-06-30 $1.73B $0.23B 13.04%
2018-03-31 $1.70B $0.13B 7.53%
2017-12-31 $1.67B $0.11B 6.78%
2017-09-30 $1.64B $0.11B 6.64%
2017-06-30 $1.62B $0.10B 6.06%
2017-03-31 $1.59B $0.18B 10.99%
2016-12-31 $1.58B $0.18B 11.29%
2016-09-30 $1.57B $0.17B 11.07%
2016-06-30 $1.57B $0.18B 11.57%
2016-03-31 $1.56B $0.19B 12.07%
2015-12-31 $1.54B $0.19B 11.98%
2015-09-30 $1.52B $0.19B 12.20%
2015-06-30 $1.50B $0.18B 11.76%
2015-03-31 $1.47B $0.17B 11.74%
2014-12-31 $1.46B $0.17B 11.62%
2014-09-30 $1.43B $0.16B 11.09%
2014-06-30 $1.41B $0.15B 10.44%
2014-03-31 $1.41B $0.13B 9.32%
2013-12-31 $1.41B $0.13B 9.41%
2013-09-30 $1.43B $0.14B 9.76%
2013-06-30 $1.45B $0.15B 10.16%
2013-03-31 $1.44B $0.16B 11.15%
2012-12-31 $1.43B $0.16B 10.98%
2012-09-30 $1.41B $0.16B 11.13%
2012-06-30 $1.40B $0.16B 11.59%
2012-03-31 $1.38B $0.16B 11.47%
2011-12-31 $1.36B $0.15B 11.37%
2011-09-30 $1.34B $0.15B 10.89%
2011-06-30 $1.32B $0.14B 10.76%
2011-03-31 $1.30B $0.14B 10.75%
2010-12-31 $1.28B $0.14B 11.17%
2010-09-30 $1.25B $0.14B 10.91%
2010-06-30 $1.22B $0.13B 10.78%
2010-03-31 $1.20B $0.13B 10.47%
2009-12-31 $1.19B $0.13B 10.67%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.450B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.733B 10.12
Quest Diagnostics (DGX) United States $15.759B 16.29
DaVita (DVA) United States $11.818B 14.68
Encompass Health (EHC) United States $8.593B 22.00
Elanco Animal Health (ELAN) United States $8.367B 21.70
Option Care Health (OPCH) United States $5.046B 19.10
RadNet (RDNT) United States $4.290B 89.34
Amedisys (AMED) United States $3.162B 22.40
LifeStance Health (LFST) United States $2.221B 0.00
Astrana Health (ASTH) United States $2.135B 28.86
Addus HomeCare (ADUS) United States $1.805B 25.82
U.S Physical Therapy (USPH) United States $1.554B 41.57
Pennant (PNTG) United States $0.695B 36.71
Aveanna Healthcare Holdings (AVAH) United States $0.543B 0.00
Atai Life Sciences (ATAI) Germany $0.280B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00